The Middle East and Africa in-vitro diagnostics (IVD) market is experiencing steady development, supported by growing healthcare investments, increasing disease prevalence, and the expansion of diagnostic infrastructure. According to Expert Market Research, the market is expected to grow at a compound annual growth rate (CAGR) of 3.20% during the forecast period 2025–2034. As diagnostic tools become more integrated with digital platforms and decentralized testing gains traction, IVD technologies are playing a central role in transforming healthcare delivery across the region.
Middle East and Africa In-vitro Diagnostics Market Size
In-vitro diagnostics refers to medical tests performed on samples (blood, urine, tissues) taken from the human body to detect diseases, conditions, or infections. The IVD sector in the Middle East and Africa is evolving rapidly, driven by the increasing demand for early and accurate disease detection, especially for infectious diseases, diabetes, and cardiovascular conditions.
Countries such as Saudi Arabia, South Africa, and the United Arab Emirates are leading the regional market due to robust healthcare infrastructure, national screening programs, and investments in laboratory modernization. Additionally, global players are forming strategic partnerships and expanding operations in these high-potential regions.
Middle East and Africa In-vitro Diagnostics Market Share
The IVD market in this region is primarily dominated by reagents and kits, which account for the largest share due to their essential role in various diagnostic techniques. Immunoassay/immunochemistry and molecular diagnostics are the most widely adopted technologies, particularly in testing for infectious diseases and oncology.
In terms of end users, hospitals and diagnostic laboratories are the major consumers of IVD products. However, homecare diagnostics is gaining ground, particularly for blood glucose self-monitoring and urinalysis, reflecting the shift toward personalized and point-of-care healthcare.
Among regional markets, Saudi Arabia and South Africa hold a significant share due to strong public health initiatives, growing medical tourism, and a rising burden of chronic diseases.
Middle East and Africa In-vitro Diagnostics Market Growth & Trends
Key factors fueling the growth of the IVD market include:
High burden of communicable and non-communicable diseases: The region continues to face challenges related to diseases like HIV/AIDS, tuberculosis, diabetes, and cancer, necessitating accurate diagnostic solutions.
Adoption of molecular diagnostics: The post-COVID era has seen a surge in demand for PCR-based tests, especially in virology and oncology. This shift has stimulated investments in genomics platforms, such as those offered by Illumina, Inc.
Digital transformation and point-of-care testing (POCT): Cloud-connected diagnostic devices and smartphone-compatible testing kits are reshaping care delivery by enabling faster, decentralized diagnosis.
Public health policies and awareness campaigns: Government-led screening initiatives and preventive care programs are expanding the market for screening test kits and self-monitoring devices.
These developments are interconnected with broader innovations in pharmaceutical cleanroom technology, which ensures the sterility, precision, and reliability of diagnostic reagents and instruments used in healthcare settings.
Middle East and Africa In-vitro Diagnostics Market Case Studies & News
In 2024, Bio-Rad Laboratories, Inc. announced the launch of a new multiplex PCR panel for infectious disease detection tailored for African healthcare labs.
Beckman Coulter, Inc. partnered with leading hospitals in the UAE to deploy automated immunoassay systems, improving throughput in emergency diagnostic testing.
Surmodics IVD, Inc., known for its reagent technologies, expanded its R&D collaborations with academic medical centers in South Africa to support localized development of diagnostic kits.
For a broader understanding of how in-vitro diagnostics operate, refer to this Wikipedia entry on In Vitro Diagnostics.
Middle East and Africa In-vitro Diagnostics Market Analysis
The regional IVD market is moderately competitive and characterized by both global players and emerging regional firms. While multinationals like Becton, Dickinson and Company and Illumina, Inc. dominate in advanced molecular platforms and automated diagnostics, smaller companies are innovating in low-cost, portable devices suited for resource-limited settings.
Regulatory frameworks are evolving, with governments increasing oversight and supporting harmonization across nations to improve diagnostic standards. For instance, the Saudi Food and Drug Authority (SFDA) and South African Health Products Regulatory Authority (SAHPRA) are focusing on streamlined approvals and quality assurance in IVD product registration.
Middle East and Africa In-vitro Diagnostics Market Segmentation
By Product and Service:
Reagents and Kits
Instruments
Software and Services
By Technology:
Immunoassay/Immunochemistry
Clinical Chemistry
Molecular Diagnostics
Haematology
Microbiology
Blood Glucose Self-Monitoring
Coagulation and Haemostasis
Urinalysis
Others
By Application:
Infectious Diseases
Diabetes
Cardiology
Oncology
Autoimmune Diseases
Nephrology
Others
By End Use:
Hospitals
Laboratories
Homecare
Others
By Region:
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others
Middle East and Africa In-vitro Diagnostics Market Key Players
Becton, Dickinson and Company
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Surmodics IVD, Inc.
Illumina, Inc.
Others
These companies are contributing significantly to the region’s diagnostic transformation through product innovation, strategic expansion, and public-private partnerships aimed at strengthening local healthcare systems.
Find More Reports
Osteoarthritis Therapeutics Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
